Only Rapid Payer Response™ (RPR) allows manufacturers to conduct a two-phase payer research project in 4 weeks at a third of the cost and time of traditional interview-based surveys

In a recent payer research project, a top ten pharmaceutical manufacturer used RPR™ to assess payer willingness to pay and perception of value for Product X, a treatment of viral induced exacerbations in patients with COPD. The survey was carried out in two phases with 20 US payers and 20 European payers:

Image 1 - v2.png

Our unique ‘semi-quant’ methodology enabled our client to gain precise and in-depth responses used to assess payer perception of value and likelihood of coverage for Product X

Due to our 'semi-quant' methodology, survey questions were elaborated in such structure allowing our client to obtain quantitative data supported by payer rationale and in-depth responses.

Findings: As a treatment of COPD exacerbations, 70% of the US payers considered it “likely” to “very likely” to be covered by their health plans. However, European payers were less positive about the value of Product X, with 65% of them suggesting that Product X might not get a positive reimbursement decision; 20% suggested that coverage will be conditional on RWD being provided and supporting patient-relevant benefits.

Image 2 - v2.png

Through RPR™ we facilitated direct engagement with payers to also understand how they will use clinical guidelines when reviewing and making coverage consideration for Product X.

In addition to our ‘semi-quant’ methodology, our technology enables for direct payer engagement with the ability to ask clarifying questions to understand use of guidelines when reviewing and making coverage consideration for Product X.

Findings: For US payers, 90% stated that they will utilize external guideline sources when making coverage determination, while 70% of European payers prefer national-level guidelines/treatment pathways.

Image 3.png

Want results like this?

Learn more about RPR™ and start getting ‘on demand’ global payer insight in a matter of days.

About Market Access Transformation (MAT)

Founded by industry veterans, MAT specializes in developing cutting edge technologies that enable the healthcare community to gather and exchange insight that assess the real-world potential of their products. MAT offers an online, information exchange platform, Rapid Payer Response™ (RPR), that allows healthcare stakeholders to secure immediate, expert feedback from the largest and most diverse online global payer network.